Transferability of clinical trials results to clinical practice: the example of new drugs for renal cell carcinoma

F. Venturini, E. Costa, P. Maimone, G. Scroccaro
2012 European journal of hospital pharmacy. Science and practice  
Conclusions Although approved indications for new drugs often resemble RCT patients' characteristics, patients treated in clinical practice differ from the study populations. This difference is also described in patients' outcome (Fig.5) .
doi:10.1136/ejhpharm-2012-000074.452 fatcat:62bnxhgy7na2fkd4ocyzedkskq